Bipolar Depression Across the Life Span: Enhancing Diagnosis and Management From Youth to Older Age

Bipolar Depression Across the Life Span: Enhancing Diagnosis and Management From Youth to Older Age

On-Demand Webcast

Melissa P. DelBello, MD, MS
Dr. Stanley and Mickey Kaplan Professor and
Chair of Psychiatry & Behavioral Neuroscience
University of Cincinnati College of Medicine
Cincinnati, Ohio

Roger S. McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Toronto, Canada

Chairman and Executive Director
Brain and Cognition Discovery Foundation
Toronto, Canada

Director, Depression and Bipolar
Support Alliance
Chicago, Illinois 

Professor and Nanshan Scholar
Guangzhou Medical University
Guangzhou, China

Adjunct Professor College of Medicine
Korea University
Seoul, Republic of Korea


For full faculty bios, please call 609-371-1137.


This activity is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.


After completing this activity, participants should be able to:

  • Describe the diagnosis and evidence-based treatment of bipolar depression in children and adolescents 
  • Formulate strategies to optimize diagnosis and management of bipolar depression in older patients
  • Discuss the significance of neurocognitive impairment in patients with bipolar disorder across the life span, including the impact of psychotropic medications

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: 03/18/2019
Expiration Date: 03/18/2020
Estimated time to complete: 1.50 hours

For questions regarding this educational activity, please call 609-371-1137.


In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1.50 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.50 contact hours.


This continuing nursing educational activity awards up to 1.50 pharmacology hours.


North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content.

Instructional Level: Advanced


The planning committee comprises Melissa DelBello, MD, MS, Roger McIntyre, MD, FRCPC, Andrew Penn, RN, MS, NP, CNS, APRN-BC, William Torrey, MD; Beth Goodwin, Rob Lowney, and Dana Ravyn, PhD, MPH, CMEology; Meaghan Benci, Raquel Gaerlan, Jennifer Ilcyn, Mary Johnson, Randy Robbin, Horacio Rodriguez, Kelly Sweeney, and Susan Yarborough, NACCME.

Independent Clinical Reviewer: 

William C. Torrey, MD
Professor and Vice Chair for Clinical Services, Dartmouth’s Geisel School of Medicine, Dartmouth-Hitchcock, Lebanon, New Hampshire

Nurse Planner: 

Andrew Penn, RN, MS, NP, CNS, APRN-BC
Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CA


According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty reported the following:

Dr. DelBello: Consultant/Advisor for Akili, Johnson & Johnson, Lundbeck, Neuronetics, Pfizer Inc., Sunovion Pharmaceuticals Inc., Supernus, and Takeda Pharmaceutical Company; Research/ Grant Support from Amarex, Johnson & Johnson, Lundbeck, Otsuka, Pfizer Inc., Shire, Sunovion Pharmaceuticals Inc., and Supernus Pharmaceuticals.

Dr. McIntyre: Consultant/Speaker for Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Janssen-Ortho Inc., Johnson & Johnson, Lundbeck, Mitsubishi, moksha8, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Purdue, Shire, Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company; Research/Grant Support from Allergan, AstraZeneca, Janssen-Ortho Inc., Lundbeck, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Purdue, Shire. 

Mr. Penn and Dr. Torrey disclosed no relevant financial relationships with any commercial interests. 

Ms. Benci, Ms. Gaerlan, Ms. Ilcyn, Mrs. Johnson, Mr. Robbin, Mr. Rodriguez, Ms. Sweeney, and Ms. Yarborough; Ms. Goodwin, Mr. Lowney, and Dr. Ravyn disclosed no relevant financial relationships with any commercial interests. 

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations. 


This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) of the United States or European Medicines Agency (EMA). Participants are encouraged to consult the EMA-approved or FDA-approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed in this document are the opinions of the presenters and do not necessarily reflect the opinions of Imedex, LLC and/or NACCME, LLC and/or CMEology.


The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to


NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC (NACCME). All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from NACCME. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering. 


This activity is jointly provided by North American Center for Continuing Medical Education, LLC, an HMP Communications Holdings Company, and CMEology.


This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc.